SEC Form 4 · accession 0001209191-17-052370
ACHIEVE LIFE SCIENCES, INC. · ACHV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Daniel Cormack
Director
Period of report
Sep 8, 2017
Accepted (ET)
Sep 12, 2017 · 2:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000949858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2017 | F | 1,491 | $3.09 | D | 14,810 | D | |
| Common Stock | holding | — | — | — | 9,685 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of restricted stock units reported by the reporting holder on August 3, 2017 in connection with the consummation of the merger on August 1, 2017 between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. and does not represent a sale by the reporting person.